Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like another tight fisted long dumped for an .0005 close today. The beast unleashed.....
Purely mythical numbers with no shot at being realized. None whatsoever.
The company expected huge VA numbers. The company expected huge NHS numbers. The company expected huge B Braun numbers. The company expected huge Mundi numbers. The company expected huge numbers from all the overseas dsitributors. What came of them....? Virtually nothing.
Same will come of this. Nothing.
Yeah - it's easy to be tight fisted when every sell is a loss - and even at that some are starting to bail.
It's over for 2020.....commence hyping 2021 immediately.
We are already seeing some of those 'tight fisted longs' who have been here for years selling their holdings and exiting; after ten years or more even the loyal ones have given up on this company and its leadership executing. They all consistently love (and use) the product, but have finally awakened to the fact that a great product alone doesn't guarantee the success of the company. BIEL won't be the first company which has a sure fire product and still winds up a complete failure as a functioning/profitable company, or one that pays off for investors.
If BIEL gets around to announcing a deal, more of those longs are going to see that as an opportunity to get out as well. Between them and the inevitable flippers, it will be another truncated rise and subsequent fall in the share price, just like the one following full body approval.
It's May, 2020 - no CE Mark, no deal announcement, no #180 day delivery, nor more company updates, no millions in sales from the VA, or B. Braun, or Mundi, or the NHS, or anyone else for that matter. Sure does make one miss the days of excitement over those CVS test stores...oh, sorry, that's right - 'retail bad - OEM good'. It never ends.....
KW is bike riding, the company is silent - even if a deal is signed it will be many weeks or months before significant revenues hit the balance sheet. Time to write the '2021 is the Year of BIEL' banners....
It's a link to the Sounds of Silence (Simon and Garfunkel) with #musicspeaks #favorite #silence
Could be a very cheeky way to set the stage for a deal announcement and (in her mind) silence the critics.
What will that do for the share price? Another run and dump for frustrated longs looking to exit and flippers making quick cash - followed by an lengthy wait for execution and more dribbling of the share price.
She appears to have inherited both her father's arrogance and his complete disregard for shareholders. Should not be a surprise to anyone who has watched the sixteen year history of this company and its ongoing complete failure to create or execute a successful business model. Ms. Whelan's first six months appear to continue the same patterns.
Each FDA clearance worth about a thousandth of a penny per share. A complete embarrassment - and worse considering how many billions of shares the Whelans have churned for money conveniently placed securely in their pockets - as KW stated herself in her SEC testimony.
Investors should be asking themselves: Where is the CE Mark? What happened to CVS? Where are the millions from B. Braun? Where are the sales from the VA? Where are the sales from Mundi? What did Kelly Whelan do with her assignment to sell product in Canada? What happened to all those overseas shipments? Where are the sales from the plethora of overseas countries where distributorships were brought in or signed agreements to move product? What happened to all the post-surgical ActiPatches that were going to be prescribed/given? Perhaps most importantly: When the OEM route fails to deliver the desired results that ALL the other pathways failed to deliver, what will be left to hype...?
All aboard!!! .0005s pushing their way in....
This will likely work out similar to the 10.3 Actipatches that post-surgical patients would be receiving.....as in will never happen.
In fact, you are correct. It's truly a tragedy - for investors, and for those seeking safe and effective means of relieving pain. Sixteen years of hype and fluff, 5 FDA approvals, and nothing to show but trips.
A true travesty worthy of an entire season of American Greed.
The train that never leaves the station.....
Once upon a time there was an engineer,
Kelly Whelan was her name we hear,
She had an engine and it didn't run,
She used billions of shares, to have some fun!
Kelly says, love shares good n' plenty,
Kelly says, really need to sell,
Kelly says, love 'em good n' plenty,
Don't know any other share scam I like so well!
Kelly was busted by the SEC,
She made millions, read her testimony,
She took over as CEO,
And nothing has changed - it easy to see!
Kelly says, #igotthisdad
Kelly says, #180days
Kelly says. #ridemybikenow
Don't know any other share scam, I like so well!
Development stage company - after 16 years. Really, the excuses here are actually worse than the overblown hype. The results, sadly, are the same -
One trip tic for each FDA approval.
Long term bagholders Dewey, Pump-em, and Howe absolutely need that new investor blood to escape the ongoing carnage. Meanwhile some are willing to sell literally billions of shares at 6 cents per share - as if.....
Bring on 2021..... we can reply it all over again for the umpteenth time.
I had no unreasonable expectations - in fact, I always expect BIEL to do exactly what it (almost) always does - fail spectacularly. I have never been disappointed.
It's been 16 years of endless hype, hyperbole, and dashed hopes for long term investors. What to show for it? Five FDA approvals and essentially a share price of .0001 for each one of those. Outstanding, isn't it?
So KW isn't communicating....what a shock (not). She made an arrogant and ridiculous guarantee - and failed. Meanwhile, she rides her bike, and no more is mentioned of the supposed 'deal' she didn't fancy (ah, so much like dad!), and all mention of CE marks, VA sales, percentages of surgeries, and 10.3 ActiPatches per patient, and the NHS paying for product, and on and on and on amount to absolutely NOTHING.
Year of BIEL after Year of BIEL the hyperbole has continued - and STILL investors get exactly .0001 - yes, one trip zero for each approval.
All aboard - the train to nowhere.
She guaranteed success in 180 days and now rides her bike in silence.
Continued failure in the grand Whelan family tradition.
#startthe2021yearofBIELmantra